10-K Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0000950170-22-002810`
Period End Date	20211231
Filing Date	20220303
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	alhc-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 48 Cash Flow Statement 117 Stockholders Equity 30

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$111.00K	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Cash	`Cash`	$466.60M	USD	Point-in-time
Cash	`Cash`	$207.31M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $111 at December 31, 2021 and $0 at December 31, 2020, respectively)	`AccountsReceivableNetCurrent`	$58.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable (less allowance for credit losses of $111 at December 31, 2021 and $0 at December 31, 2020, respectively)	`AccountsReceivableNetCurrent`	$40.14M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.23M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$27.75M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$264.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$552.86M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	164.06M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$30.36M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$11.13M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.89M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$7.85M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$34.65M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$35.12M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	164.06M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.19M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.71M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$2.15M	USD	Point-in-time
Total assets	`Assets`	$338.50M	USD	Point-in-time
Total assets	`Assets`	$630.89M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$112.61M	USD	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$125.89M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$17.43M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$15.68M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$23.93M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$25.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$167.25M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$153.45M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$144.17M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$150.62M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$6.97M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$10.27M	USD	Point-in-time
Total liabilities	`Liabilities`	$307.89M	USD	Point-in-time
Total liabilities	`Liabilities`	$324.84M	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of December 31, 2021 and December 31, 2020, respectively; no shares issued and outstanding as of December 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of December 31, 2021 and December 31, 2020, respectively; no shares issued and outstanding as of December 31, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 187,193,613 and 164,063,787 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$164.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 187,193,613 and 164,063,787 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively	`CommonStockValue`	$188.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$410.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$880.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-379.57M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-574.86M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$30.61M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$306.04M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-33.66M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$338.50M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$630.89M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$1.17B	USD	Annual
Earned premiums	`PremiumsEarnedNet`	$955.39M	USD	Annual
Earned premiums	`PremiumsEarnedNet`	$753.97M	USD	Annual
Other	`RevenueNotFromContractWithCustomer`	$688.00K	USD	Annual
Other	`RevenueNotFromContractWithCustomer`	$3.83M	USD	Annual
Other	`RevenueNotFromContractWithCustomer`	$2.99M	USD	Annual
Total revenues	`Revenues`	$1.17B	USD	Annual
Total revenues	`Revenues`	$959.22M	USD	Annual
Total revenues	`Revenues`	$756.96M	USD	Annual
Medical expenses	`MedicalExpenses`	$792.99M	USD	Annual
Medical expenses	`MedicalExpenses`	$661.39M	USD	Annual
Medical expenses	`MedicalExpenses`	$1.04B	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$290.99M	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$156.40M	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$110.13M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.81M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.10M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.92M	USD	Annual
Total expenses	`OperatingExpenses`	$1.35B	USD	Annual
Total expenses	`OperatingExpenses`	$964.49M	USD	Annual
Total expenses	`OperatingExpenses`	$786.45M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-29.48M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-178.07M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-5.26M	USD	Annual
Interest expense	`InterestExpense`	$16.93M	USD	Annual
Interest expense	`InterestExpense`	$17.44M	USD	Annual
Interest expense	`InterestExpense`	$14.90M	USD	Annual
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-229.00K	USD	Annual
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$351.00K	USD	Annual
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$732.00K	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-17.21M	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-17.66M	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-15.25M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-195.29M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.93M	USD	Annual
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.73M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-195.29M	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-44.73M	USD	Annual
Net loss attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-22.93M	USD	Annual
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	171.96M	shares	Annual
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	135.86M	shares	Annual
Total weighted-average common shares outstanding - basic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	152.13M	shares	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.33	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.15	USD	Annual
Net loss per share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.14	USD	Annual

Cash Flow Statement 117 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-44.73M	USD	Annual
Net loss	`ProfitLoss`	$-22.93M	USD	Annual
Net loss	`ProfitLoss`	$-195.29M	USD	Annual
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$118.00K	USD	Annual
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$111.00K	USD	Annual
Provision for credit loss	`ProvisionForDoubtfulAccounts`	$1.42M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$16.58M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$15.46M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$16.03M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$2.25M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.95M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$2.19M	USD	Annual
Payment-in-kind interest	`PaidInKindInterest`	$4.20M	USD	Annual
Payment-in-kind interest	`PaidInKindInterest`	$4.01M	USD	Annual
Payment-in-kind interest	`PaidInKindInterest`	$3.41M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.01M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-418.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$2.12M	USD	Annual
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$1.16M	USD	Annual
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$110.60M	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$2.32M	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	-	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$2.73M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.63M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$17.61M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.78M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$11.99M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.68M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.34M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.15M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.78M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-644.00K	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$36.57M	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$6.46M	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$12.51M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.29M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$437.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$645.00K	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-1.24M	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$12.65M	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-196.00K	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-3.82M	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	-	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$1.28M	USD	Annual
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	$-1.36M	USD	Annual
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	$-3.94M	USD	Annual
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	-	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.56M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-78.78M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.21M	USD	Annual
Asset acquisition, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	Annual
Asset acquisition, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	-	USD	Annual
Asset acquisition, net of cash received	`PaymentsToAcquireAssetsInvestingActivities`	$1.41M	USD	Annual
Purchase of investments	`PaymentsToAcquireInvestments`	$320.00K	USD	Annual
Purchase of investments	`PaymentsToAcquireInvestments`	$1.57M	USD	Annual
Purchase of investments	`PaymentsToAcquireInvestments`	$2.48M	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$325.00K	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$1.43M	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$825.00K	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-10.24M	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-15.71M	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-18.36M	USD	Annual
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$100.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.36M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.82M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.24M	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$55.00M	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Debt issuance costs	`DebtIssuanceCosts`	-	USD	Annual
Debt issuance costs	`DebtIssuanceCosts`	-	USD	Annual
Debt issuance costs	`DebtIssuanceCosts`	$-854.00K	USD	Annual
Purchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$15.00K	USD	Annual
Purchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Purchase of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.98M	USD	Annual
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.47M	USD	Annual
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.50M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$500.00K	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$390.60M	USD	Annual
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$135.00M	USD	Annual
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$3.37M	USD	Annual
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	-	USD	Annual
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$29.01M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$130.12M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$52.66M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$360.13M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$51.63M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$260.54M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$121.33M	USD	Annual
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.85M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.85M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$10.99M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$10.72M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$9.53M	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$366.00K	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$106.00K	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$347.00K	USD	Annual
Cash	`CashAndCashEquivalentsAtCarryingValue`	$207.31M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$86.48M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$466.60M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	-	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$1.75M	USD	Point-in-time
Restricted cash in other assets	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.85M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$468.35M	USD	Point-in-time
Total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time

Stockholders Equity 30 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-33.66M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-195.29M	USD	Annual
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-44.73M	USD	Annual
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-22.93M	USD	Annual
Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	Annual
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	Annual
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$1.04M	USD	Point-in-time
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$361.59M	USD	Annual
Issuance of common stock, net of issuance costs, Shares	`StockIssuedDuringPeriodSharesNewIssues`	9.20M	shares	Point-in-time
Issuance of common stock, net of issuance costs, Shares	`StockIssuedDuringPeriodSharesNewIssues`	131,629.00	shares	Annual
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	$6.48M	USD	Annual
Issuance of common stock to stock appreication rights holders	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.51M	USD	Annual
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	$1.00K	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.12M	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.16M	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$92.61M	USD	Annual
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.47M	USD	Annual
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.48M	USD	Annual
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.50M	USD	Annual
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$306.06M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-33.66M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.19M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.